FCBT
ALXN

First Citizens Bank & Trust’s Alexion Pharmaceuticals ALXN Stock Holding History

First Citizens Bank & Trust’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,165
Closed -$948K – 444
2021
Q2 		$948K Sell
5,165
-113
-2% -$19.4K 0.04% 170
2021
Q1 		$807K Buy
5,278
+157
+3% +$24.3K 0.04% 197
2020
Q4 		$800K Sell
5,121
-673
-12% -$86.5K 0.04% 191
2020
Q3 		$663K Sell
5,794
-364
-6% -$39.3K 0.05% 199
2020
Q2 		$691K Sell
6,158
-6,263
-50% -$665K 0.06% 201
2020
Q1 		$1.11M Buy
+12,421
New +$1.22M 0.13% 143
2015
Q1 		– Sell
-3,185
Closed -$589K – 418
2014
Q4 		$589K Buy
+3,185
New +$590K 0.05% 234
2013
Q4 		– Sell
-18,449
Closed -$2.14M – 866
2013
Q3 		$2.14M Buy
18,449
+663
+4% +$72.7K 0.08% 227
2013
Q2 		$1.64M Buy
+17,786
New +$1.71M 0.07% 265

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

First Citizens Bank & Trust's ALXN Position: Q3 2021 in Review

First Citizens Bank & Trust sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 5,165 shares — an estimated $948K sold.

First Citizens Bank & Trust first reported a position in ALXN in Q2 2013 and held it in 9 quarters. The position peaked at $2.14M in Q3 2013. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • First Citizens Bank & Trust reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • First Citizens Bank & Trust sold 5,165 Alexion Pharmaceuticals shares in Q3 2021, an estimated $948K.
  • First Citizens Bank & Trust first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 9 quarters.
  • First Citizens Bank & Trust's Alexion Pharmaceuticals position peaked at $2.14M in Q3 2013.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on First Citizens Bank & Trust's 13F filing for Q3 2021, filed 15 Oct 2021.